78
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Challenges in Developing Novel DNA Methyltransferases Inhibitors for Cancer Therapy

&
Pages 1237-1240 | Published online: 27 Aug 2014

References

  • Jurkowska RZ , JurkowskiTP, JeltschA. Structure and function of mammalian DNA methyltransferases. Chembiochem.12 (2), 206–222 (2011).
  • Weber M , HellmannI, StadlerMBet al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet.39 (4), 457–466 (2007).
  • Baylin SB , JonesPA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11 (10), 726–734 (2011).
  • Mai A , AltucciL. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Int. J. Biochem. Cell Biol.41 (1), 199–213 (2009).
  • Issa J-PJ , KantarjianHM. Targeting DNA methylation. Clin. Cancer Res.15 (12), 3938–3946 (2009).
  • Stresemann C , LykoF. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int. J. Cancer.123 (1), 8–13 (2008).
  • Juergens RA , WrangleJ, VendettiFPet al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discovery1 (7), 598–607 (2011).
  • ClinicalTrials.gov . www.clinicaltrials.gov
  • Boumber Y , KantarjianH, JorgensenJet al. A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission. Leukemia.26 (11), 2428–2431 (2012).
  • Chuang JC , WarnerSL, VollmerDet al. S110, a 5-aza-2’-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Mol. Cancer Ther.9 (5), 1443–1450 (2010).
  • Fang MZ , ChenD, SunY, JinZ, ChristmanJK, YangCS. Reversal of hypermethylation and reactivation of p16INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res.11 (19), 7033–7041 (2005).
  • Ceccaldi A , RajaveluA, ChampionCet al. C5-DNA methyltransferase inhibitors: from screening to effects on zebrafish embryo development. Chembiochem.12 (9), 1337–1345 (2011).
  • Brueckner B , BoyRG, SiedleckiPet al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res.65 (14), 6305–6311 (2005).
  • Datta J , GhoshalK, DennyWAet al. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res.69 (10), 4277–4285 (2009).
  • Ceccaldi A , RajaveluA, RagozinSet al. Identification of novel inhibitors of DNA methylation by screening of a chemical library. ACS Chem. Biol.8 (3), 543–548 (2013).
  • Fagan RL , WuM, ChédinF, BrennerC. An ultrasensitive high throughput screen for DNA methyltransferase 1-targeted molecular probes. PLoS ONE8 (11), e78752 (2013).
  • Kilgore JA , DuX, MelitoLet al. Identification of DNMT1 selective antagonists using a novel scintillation proximity assay. J. Biol. Chem.288 (27), 19673–19684 (2013).
  • Gros C , ChauvignéL, PouletAet al. Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies. Nucleic Acids Res.41 (19), e185 (2013).
  • Song J , RechkoblitO, BestorTH, PatelDJ. Structure of DNMT1–DNA complex reveals a role for auto inhibition in maintenance DNA methylation. Science331 (6020), 1036–1040 (2011).
  • Song J , TeplovaM, Ishibe-MurakamiS, PatelDJ. Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation. Science335 (6069), 709–712 (2012).
  • Takeshita K , SuetakeI, YamashitaEet al. Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1). Proc. Natl Acad. Sci. USA108 (22), 9055–9059 (2011).
  • Jia D , JurkowskaRZ, ZhangX, JeltschA, ChengX. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature449 (7159),  248–251  (2007).
  • Yoo J , Medina-FrancoJL. Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase. J. Comput. Aided Mol. Des.25 (6), 555–567 (2011).
  • Asgatay S , ChampionC, MarloieGet al. Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. J. Med. Chem.57 (2), 421–434 (2014).
  • Yu W , ChoryEJ, WernimontAKet al. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat. Commun.3, 1288 (2012).
  • Filippakopoulos P , QiJ, PicaudSet al. Selective inhibition of BET bromodomains. Nature468 (7327), 1067–1073 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.